Bladder Cancer - Results from #160

Update on Phase 3 KEYNOTE-361 Trial Evaluating Pembrolizumab as Monotherapy and in Combination with Chemotherapy in Patients with Advanced or Metastatic Urothelial Carcinoma June 10, 2020

Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles. June 10, 2020

PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? June 10, 2020

A Machine Learning Approach for Long-Term Prognosis of Bladder Cancer based on Clinical and Molecular Features. June 10, 2020

[First-line treatment of metastatic urothelial carcinoma : Update immuno-oncology]. June 9, 2020

Radical Cystectomy and Ileal Conduit Diversion for Bladder Urothelial Carcinoma With Sarcomatoid and Squamous Variants After Renal Transplantation. June 9, 2020

Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage. June 9, 2020

Treating Elderly Patients With Muscle-Invasive Bladder Cancer. June 8, 2020

Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer. June 8, 2020

The effect of urinary diversion on long-term kidney function after cystectomy. June 8, 2020

Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells. June 5, 2020

Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan. June 5, 2020

[Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments]. June 5, 2020

The effect of surgical trauma on circulating free DNA levels in cancer patients - implications for studies of circulating tumor DNA. June 4, 2020

Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. June 4, 2020

"Katz activities of daily living disability in older cancer survivors by age, stage, and cancer type". June 3, 2020

Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer. June 3, 2020

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results. June 3, 2020

[Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer]. June 2, 2020

Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study. June 2, 2020

Page 9 of 354